These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 36222542)
1. ADAMTS12, a novel prognostic predictor, promotes cell proliferation, migration, and invasion in head and neck squamous cell carcinoma. Li M; Yuan Z; Tang Z Oral Dis; 2024 Mar; 30(2):235-246. PubMed ID: 36222542 [TBL] [Abstract][Full Text] [Related]
2. Syntenin-1 is a promoter and prognostic marker of head and neck squamous cell carcinoma invasion and metastasis. Cui L; Cheng S; Liu X; Messadi D; Yang Y; Hu S Oncotarget; 2016 Dec; 7(50):82634-82647. PubMed ID: 27811365 [TBL] [Abstract][Full Text] [Related]
3. IFIT3 accelerates the progression of head and neck squamous cell carcinoma by targeting PD-L1 to activate PI3K/AKT signaling pathway. Liu P; Kong X; Yi S; Chen Y; Luo W World J Surg Oncol; 2024 Jan; 22(1):34. PubMed ID: 38273364 [TBL] [Abstract][Full Text] [Related]
4. TRIB3, as a robust prognostic biomarker for HNSC, is associated with poor immune infiltration and cancer cell immune evasion. Wu H; Fu Z; Li H; Fang F; He B; Ye Y; Wu H; Xu D; Zheng H; Zhang Q Front Immunol; 2023; 14():1290839. PubMed ID: 38235126 [TBL] [Abstract][Full Text] [Related]
5. Sterol regulatory element binding transcription factor 1 promotes proliferation and migration in head and neck squamous cell carcinoma. Tan M; Lin X; Chen H; Ye W; Yi J; Li C; Liu J; Su J PeerJ; 2023; 11():e15203. PubMed ID: 37090107 [TBL] [Abstract][Full Text] [Related]
6. Constructing a prognostic model for head and neck squamous cell carcinoma based on glucose metabolism related genes. Liu Y; Liu N; Zhou X; Zhao L; Wei W; Hu J; Luo Z Front Endocrinol (Lausanne); 2023; 14():1245629. PubMed ID: 37876534 [TBL] [Abstract][Full Text] [Related]
7. Integrated analysis of diagnostic, prognostic value and potential drug treatment of GSDME in head and neck squamous cell carcinoma. Hu R; Lu M; She L Eur Arch Otorhinolaryngol; 2023 Sep; 280(9):4239-4253. PubMed ID: 37204444 [TBL] [Abstract][Full Text] [Related]
8. Identification of SLC2A3 as a prognostic indicator correlated with the NF-κB/EMT axis and immune response in head and neck squamous cell carcinoma. Chai F; Zhang J; Fu T; Jiang P; Huang Y; Wang L; Yan S; Yan X; Yu L; Xu Z; Wang R; Xu B; Du X; Jiang Y; Zhang J Channels (Austin); 2023 Dec; 17(1):2208928. PubMed ID: 37134043 [TBL] [Abstract][Full Text] [Related]
9. CCR5 as a prognostic biomarker correlated with immune infiltrates in head and neck squamous cell carcinoma by bioinformatic study. Li C; Chen S; Liu C; Mo C; Gong W; Hu J; He M; Xie L; Hou X; Tang J; Ou M Hereditas; 2022 Sep; 159(1):37. PubMed ID: 36167571 [TBL] [Abstract][Full Text] [Related]
10. Expression and prognostic analysis of BGN in head and neck squamous cell carcinoma. Zhao L; Liang J; Zhong W; Han C; Liu D; Chen X Gene; 2022 Jun; 827():146461. PubMed ID: 35358652 [TBL] [Abstract][Full Text] [Related]
11. Systematic analysis of expression and prognostic significance for MCM family in head and neck squamous cell carcinoma. Sun E; Peng L; Liu Z; Yan Z; Chen M; Zheng J Histol Histopathol; 2024 Apr; 39(4):471-482. PubMed ID: 37526267 [TBL] [Abstract][Full Text] [Related]
12. ADAMTS12 promotes migration and epithelial-mesenchymal transition and predicts poor prognosis for pancreatic cancer. He RZ; Zheng JH; Yao HF; Xu DP; Yang MW; Liu DJ; Sun YW; Huo YM Hepatobiliary Pancreat Dis Int; 2023 Apr; 22(2):169-178. PubMed ID: 35508435 [TBL] [Abstract][Full Text] [Related]
13. MRGBP: A New Factor for Diagnosis and Prediction of Head and Neck Squamous Cell Carcinoma. Zhao C; Wei C; Chen X; Li P Biomed Res Int; 2022; 2022():7281120. PubMed ID: 35924262 [TBL] [Abstract][Full Text] [Related]
14. Epithelial to mesenchymal transition in head and neck squamous carcinoma: association of Src activation with E-cadherin down-regulation, vimentin expression, and aggressive tumor features. Mandal M; Myers JN; Lippman SM; Johnson FM; Williams MD; Rayala S; Ohshiro K; Rosenthal DI; Weber RS; Gallick GE; El-Naggar AK Cancer; 2008 May; 112(9):2088-100. PubMed ID: 18327819 [TBL] [Abstract][Full Text] [Related]
15. CCR4 is a prognostic biomarker and correlated with immune infiltrates in head and neck squamous cell carcinoma. Zhang Y; Chen K; Li L; Mao W; Shen D; Yao N; Zhang L Ann Transl Med; 2021 Sep; 9(18):1443. PubMed ID: 34733995 [TBL] [Abstract][Full Text] [Related]
16. Identification of the MMP family as therapeutic targets and prognostic biomarkers in the microenvironment of head and neck squamous cell carcinoma. Liu M; Huang L; Liu Y; Yang S; Rao Y; Chen X; Nie M; Liu X J Transl Med; 2023 Mar; 21(1):208. PubMed ID: 36941602 [TBL] [Abstract][Full Text] [Related]
17. NT5E upregulation in head and neck squamous cell carcinoma: A novel biomarker on cancer-associated fibroblasts for predicting immunosuppressive tumor microenvironment. Chen XM; Liu YY; Tao BY; Xue XM; Zhang XX; Wang LL; Zhong H; Zhang J; Yang SM; Jiang QQ Front Immunol; 2022; 13():975847. PubMed ID: 36091055 [TBL] [Abstract][Full Text] [Related]
18. FOXD1 expression in head and neck squamous carcinoma: a study based on TCGA, GEO and meta-analysis. Huang J; Liang B; Wang T Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34269372 [TBL] [Abstract][Full Text] [Related]
19. Lysine Methyltransferase 2D Regulates Immune Response and Metastasis in Head and Neck Cancer. Wu J; Chun C; Lagunas AM; Crowe DL Anticancer Res; 2024 Aug; 44(8):3231-3242. PubMed ID: 39060071 [TBL] [Abstract][Full Text] [Related]